Returning search results with filters:
Remove filter forAudience: Healthcare
Remove filter forIssue: COVID Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 3 of 3 items.
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
… Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir Starting date: September 8, 2020 Posting date: … for Canadian patients ahead of the Canadian-labelled VEKLURY being marketed. Healthcare professionals are advised …
AlertHealth professional risk communication | 2020-09-15
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
… Remdesivir authorized with conditions for the treatment of … â Health Canada has authorized with conditions the drug remdesivir (brand name Veklury) manufactured by Gilead Sciences Canada, Inc. for the …
AlertPublic advisory | 2020-07-28
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
… granted authorization with conditions for the use of Veklury (remdesivir) to treat COVID-19 in patients with pneumonia requiring supplemental oxygen. Remdesivir is the first drug to be authorized in Canada for …
AlertInformation update | 2020-04-25